$NVO INSIGHTS →Novo Nordisk is launching discounted U.S. self-pay subscriptions for Wegovy to regain share from Eli Lilly, offering monthly prices up to nearly 30% below its standard rate.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →